close

Mergers and Acquisitions

1 7 8 9 10 11 33
Number of results: 648
Date Acquired company Acquiring company Amount Related
2016-06-03 Amarantus Diagnostics Avant Diagnostics

Cancer - Oncology

Neurodegenerative diseases

Diagnostic

2016-06-01 Tokalas (USA - CA) Oncternal Therapeutics (USA - CA) Cancer - Oncology - Rare diseases
2016-05-31 Effimune (France) OSE Pharma (France)

Cancer - Oncology

Immunotherapy

2016-05-31 Celator Pharmaceuticals (USA - NY) Jazz Pharmaceuticals (Ireland) $1.5 billion

Cancer - Oncology

2016-05-31 Italchimici (Italy) Recordati (Italy) € 130 million Gastrointestinal diseases - Respiratory diseases
2016-05-27 FEI (USA - OR) Thermo Fisher Scientific (USA - MA) $4.2 billion
2016-05-13 non-sterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings (Canada - USA) Mylan (USA - PA) $950 million (€835 million)

Generics

2016-05-11 Alizé Pharma II (France) Jazz Pharmaceuticals (Ireland) up to €18 million

Cancer - Oncology

Rare diseases

2016-05-10 Kuecept (UK) Aptuit (UK) undisclosed

Technology - Services

2016-05-05 IMS Health (USA - CT) Quintiles (USA - NC)

Clinical research

Technology - Services

2016-05-05 Prime European Therapeuticals/Euticals (Italy) AMRI (USA - NY) € 315 million

Technology - Services

manufacturing

production

2016-05-02 Bioject Medical Technologies (USA) Inovio Pharmaceuticals (USA - PA) $5.5 million (€ 4.92 million)

Technology - Services

2016-04-29 4SC Discovery (Germany) BioNTech Small Molecules (Germany) € 0.65 million

Technology - Services

2016-04-28 Stemcentrx (USA - CA) Abbvie (USA -IL) up to $ 9.8 billion (€ 8.65 billion)

Cancer - Oncology

2016-04-28 Rentschler Biotechnologie's Adeno-Associated Virus (AAV) manufacturing platform Freeline Therapeutics (UK) undisclosed

Manufacturing

Production

Gene therapy

2016-04-25 NTD (PerkinElmer’s U.S. prenatal screening laboratory services business) (USA - NY) Eurofins Scientific (Luxembourg) undisclosed

Diagnostic

genomic testing

2016-04-21 Topokine Therapeutics (USA - MA) Allergan (Ireland) $85 million and success-based development and sales milestones

Ophtalmological diseases

Aesthetic medicine

2016-04-21 Exquiron Biotech (Switzerland) Aptuit (UK) undisclosed

Technology - Services

2016-04-18 Cytonet's assets (Germany) Promethera Biosciences (Belgium) undisclosed

cell therapy

regenerative medicine

liver diseases

hepatic diseases

2016-04-15 Crelux (Germany) WuXi AppTec (China) undisclosed

Technology - Services